Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Christopher M. Deibert
Disparities in the Treatment of Patients With IL-2 for Metastatic Renal Cell Carcinoma
Urologic Oncology: Seminars and Original Investigations
Oncology
Urology
Related publications
Durability of Responses in Patients With Metastatic Renal Cell Carcinoma Treated With High Dose Interleukin-2 (HD IL-2)
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma
Therapeutic Advances in Urology
Urology
High-Dose Interleukin 2 in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Features
PLoS ONE
Multidisciplinary
Phase 1 Trial of Allogeneic Gene-Modified Tumor Cell Vaccine RCC-26/CD80/IL-2 in Patients With Metastatic Renal Cell Carcinoma
Human Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Nonablative Hematopoietic Cell Transplantation for the Treatment of Metastatic Renal Cell Carcinoma
Bone Marrow Transplantation
Transplantation
Hematology
New Systemic Approaches in the Treatment of Metastatic Renal Cell Carcinoma
Intravenous Interleukin-2 in Patients Over 65 With Metastatic Renal Carcinoma
British Journal of Cancer
Cancer Research
Oncology
Prognosis of Patients With Metastatic Renal Cell Carcinoma and Pancreatic Metastases
BJU International
Urology
Quality of Life of Patients With Advanced/Metastatic Renal Cell Carcinoma During the Treatment Period With Targeted Drugs
Üroonkoloji Bülteni